View Older Stories View More Recent Stories

Apr 19, 2023 07:30AM Relay Therapeutics to Participate in Two Upcoming Investor Conferences
Apr 19, 2023 07:30AM Relay Therapeutics to Participate in Two Upcoming Investor Conferences
Apr 18, 2023 10:40AM Relay Therapeutics (RLAY) Announces Initial Clinical Data Demonstrating that RLY-2608 Selectively Targets Multiple PI3Ka Mutations
Apr 18, 2023 10:40AM Relay Therapeutics Announces Initial Clinical Data Demonstrating that RLY-2608 Selectively Targets Multiple PI3Kα Mutations
Apr 18, 2023 10:40AM Relay Therapeutics Announces Initial Clinical Data Demonstrating that RLY-2608 Selectively Targets Multiple PI3Kα Mutations
Mar 6, 2023 07:30AM Relay Therapeutics to Present Initial Clinical Data on RLY-2608 at AACR
Mar 6, 2023 07:30AM Relay Therapeutics to Present Initial Clinical Data on RLY-2608 at AACR
Mar 1, 2023 07:30AM Relay Therapeutics to Participate in Two Upcoming Investor Conferences
Mar 1, 2023 07:30AM Relay Therapeutics to Participate in Two Upcoming Investor Conferences
Feb 23, 2023 04:05PM Relay Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Highlights
Feb 23, 2023 04:05PM Relay Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Highlights
Feb 16, 2023 04:05PM Relay Therapeutics to Announce Fourth Quarter and Full Year 2022 Financial Results and Corporate Highlights
Feb 16, 2023 04:05PM Relay Therapeutics to Announce Fourth Quarter and Full Year 2022 Financial Results and Corporate Highlights
Feb 2, 2023 07:30AM Relay Therapeutics to Participate in Guggenheim Healthcare Talks | Oncology Day
Feb 2, 2023 07:30AM Relay Therapeutics to Participate in Guggenheim Healthcare Talks | Oncology Day
Jan 3, 2023 07:30AM Relay Therapeutics to Present at 41st Annual J.P. Morgan Healthcare Conference
Jan 3, 2023 07:30AM Relay Therapeutics to Present at 41st Annual J.P. Morgan Healthcare Conference
Nov 7, 2022 07:30AM Relay Therapeutics to Participate in Two Upcoming Investor Conferences
Nov 7, 2022 07:30AM Relay Therapeutics to Participate in Two Upcoming Investor Conferences
Nov 3, 2022 04:05PM Relay Therapeutics Reports Third Quarter 2022 Financial Results and Corporate Highlights
Nov 3, 2022 04:05PM Relay Therapeutics Reports Third Quarter 2022 Financial Results and Corporate Highlights
Oct 27, 2022 04:05PM Relay Therapeutics to Announce Third Quarter 2022 Financial Results and Corporate Highlights
Oct 27, 2022 04:05PM Relay Therapeutics to Announce Third Quarter 2022 Financial Results and Corporate Highlights
Sep 26, 2022 07:30AM Relay Therapeutics to Participate in Fireside Chat at Bank of America Securities 2022 Precision Oncology Conference
Sep 26, 2022 07:30AM Relay Therapeutics to Participate in Fireside Chat at Bank of America Securities 2022 Precision Oncology Conference
Sep 12, 2022 06:31AM Relay Therapeutics (RLAY) and Foundation Medicine Collaborate for Development of FoundationOne CDX and RLY-4008
Sep 12, 2022 06:30AM Foundation Medicine and Relay Therapeutics Collaborate to Develop FoundationOne®CDx as a Companion Diagnostic for Relay’s Investigational FGFR2 Inhibitor, RLY-4008
Sep 12, 2022 05:38AM Relay Therapeutics (RLAY) Reports New Interim Data for RLY-4008
Sep 11, 2022 09:45AM Late Breaking Data Presented at ESMO Congress 2022 Demonstrate Potential of RLY-4008 to Transform Treatment Options for Cholangiocarcinoma Patients with FGFR2-Driven Disease
Sep 11, 2022 09:45AM Late Breaking Data Presented at ESMO Congress 2022 Demonstrate Potential of RLY-4008 to Transform Treatment Options for Cholangiocarcinoma Patients with FGFR2-Driven Disease
Aug 18, 2022 04:05PM Relay Therapeutics to Present Clinical Data on RLY-4008 at ESMO Congress
Aug 18, 2022 04:05PM Relay Therapeutics to Present Clinical Data on RLY-4008 at ESMO Congress
Aug 4, 2022 04:05PM Relay Therapeutics Reports Second Quarter 2022 Financial Results and Corporate Highlights
Aug 4, 2022 04:05PM Relay Therapeutics Reports Second Quarter 2022 Financial Results and Corporate Highlights
Jul 28, 2022 04:05PM Relay Therapeutics to Announce Second Quarter 2022 Financial Results and Corporate Highlights
Jul 28, 2022 04:05PM Relay Therapeutics to Announce Second Quarter 2022 Financial Results and Corporate Highlights
Jun 27, 2022 06:01AM Relay Therapeutics (RLAY) Discloses Anticipated Registrational Path for RLY-4008
Jun 27, 2022 06:00AM Relay Therapeutics Discloses Anticipated Registrational Path for RLY-4008 in Cholangiocarcinoma and Growing Breast Cancer Franchise at Virtual Analyst and Investor Event
Jun 27, 2022 06:00AM Relay Therapeutics Discloses Anticipated Registrational Path for RLY-4008 in Cholangiocarcinoma and Growing Breast Cancer Franchise at Virtual Analyst and Investor Event
Jun 16, 2022 07:30AM Relay Therapeutics Announces Timing of Virtual Analyst and Investor Event
Jun 16, 2022 07:30AM Relay Therapeutics Announces Timing of Virtual Analyst and Investor Event
May 26, 2022 07:30AM Relay Therapeutics to Participate in Two Upcoming Investor Conferences
May 26, 2022 07:30AM Relay Therapeutics to Participate in Two Upcoming Investor Conferences
May 5, 2022 04:05PM Relay Therapeutics Reports First Quarter 2022 Financial Results and Corporate Highlights
May 5, 2022 04:05PM Relay Therapeutics Reports First Quarter 2022 Financial Results and Corporate Highlights
May 3, 2022 07:30AM Relay Therapeutics to Participate in Fireside Chat at Bank of America Securities 2022 Healthcare Conference
May 3, 2022 07:30AM Relay Therapeutics to Participate in Fireside Chat at Bank of America Securities 2022 Healthcare Conference
Apr 28, 2022 04:05PM Relay Therapeutics to Announce First Quarter 2022 Financial Results and Corporate Highlights
Apr 28, 2022 04:05PM Relay Therapeutics to Announce First Quarter 2022 Financial Results and Corporate Highlights
Feb 24, 2022 04:05PM Relay Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Highlights
View More Recent Stories View Older Stories